INSIGHTS ON DRUG DEVELOPMENT
-
![Your AKTA Oligosynt system]( "Your AKTA Oligosynt™ System : It's More Than A Machine")
Your AKTA Oligosynt™ System : It's More Than A MachineDiscover how early choices in oligo synthesis workflows shape performance. Learn what to consider across design, reagents, and system optimization to build a process ready for smooth scale‑up.
-
![drug-products-percision-medicine-GettyImages-1395657542]( "Making Accelerated Predictive Stability Studies Even Faster With Software")
Making Accelerated Predictive Stability Studies Even Faster With SoftwareDrug stability depends on environmental conditions, but testing every scenario experimentally isn’t practical. Accelerated predictive stability uses mathematical modeling to forecast degradation, helping scientists make faster, data-driven decisions early in development.
-
![GettyImages-1324475324 Lab]( "Can Collaboration Close Biopharma's Talent Gap For Good?")
Can Collaboration Close Biopharma's Talent Gap For Good?Biopharma innovation is accelerating, but workforce shortages threaten progress. See how strengthening collaboration is essential to developing the skills needed for emerging therapies.
-
![data-analytics-edc-GettyImages-2150332083]( "The Analytical Advantage Across The Development Lifecycle")
The Analytical Advantage Across The Development LifecycleIntegrated, regulatory‑ready analytics help accelerate development, strengthen submissions, and ensure consistent product quality throughout the pharmaceutical lifecycle.
-
Using Residual DNA Quantification Data To De-Risk mAb Development6/11/2026
Residual DNA quantitation offers more than impurity measurement. When used across process steps, it helps compare purification performance, identify risks early, and ensure assays remain reliable.
-
Accelerating Method Development And Manufacturing Of GLP-1 Analogs7/29/2025
Explore a streamlined LC-UV/MS workflow that empowers labs to meet rising GLP-1 drug demand with faster, more informed decisions that enhance compliance and impurity detection efficiency.
-
Aggregation In Antibody-Drug Conjugates: Causes And Mitigation9/1/2025
Discover how early intervention in ADC development can streamline clinical progress, ensure stability and safety, and accelerate commercialization with expert guidance.
-
Role Of Chronic Inflammation In Risk For Neurodegenerative Disorders: Alzheimer's Disease10/8/2024
Explore how genetic and environmental risk factors interact to heighten Alzheimer's disease risk, and gain insight into a novel therapeutic approach.
-
Cell Culture Media Demystified For Performance, Quality, And Innovation11/13/2025
Cell culture media isn’t one-size-fits-all. Learn how media composition, customization, and analytics can dramatically improve cell growth, productivity, and product quality for complex processes.
DRUG DEVELOPMENT SOLUTIONS
-
![leica-microsystems-cell-dive-hero]( "Transforming Tissue Research With Open Multiplexing")
Cell DIVE Multiplex Imaging Solution
What if every scientist could map normal and diseased tissue by cell type, biomarker profile, and specific features?
Cell DIVE is a precise, open multiplexing solution that lets your research dictate the level of automation required, which antibodies to use, how to build your antibody panel, and more.
-
![GettyImages-1127105013-lab-computer-research-scientist]( "Solid Form Services")
We have defined work flows to assess and select solid forms in a cost and time efficient manner that meets the needs of each individual program.
-
![Thermo - EfficientPro]( "Drive Your Performance Forward With The Expanded Family Of Efficient-Pro Feeds")
Enhance your protein production with a next-generation feed specifically designed to boost the performance of CHO-K1 GS cell lines.
-
![Waters ACQUITY Premier Column Family]( "MaxPeak Premier Columns For Peptide Analysis")
MaxPeak™ Premier Columns utilize MaxPeak High Performance Surfaces that are designed to increase analyte recovery, sensitivity, and reproducibility by minimizing analyte/surface interactions that can lead to sample losses.
-
![leica-microsystems-stellaris-sted-hero]( "Fast Imaging Beyond The Diffraction Limit With STELLARIS STED Microscopes")
STELLARIS STED Microscope
Get faster to the truth
Our STED (stimulated emission depletion) technology joins the STELLARIS platform to provide you the fastest way of imaging beyond the diffraction limit. Obtain cutting-edge nanoscopy results in no time with astounding image quality and resolution, while protecting your sample. STED super-resolution allows you to study multiple dynamic events simultaneously, so you can investigate molecular relationships and mechanisms within the cellular context.
The seamless integration of STED and STELLARIS provides easy access to STED directly from the confocal interface, making it just a few clicks away. Now you can get more insights from your sample, because every detail matters.
